Woman, 66 years old, gives birth to her 10th child: People 'should have more children'
A 66-year-old woman in Germany has given birth to her 10th child.
Alexandra Hildebrandt, owner of the Wall Museum at Checkpoint Charlie in Berlin, welcomed her new son, Philipp, on March 19, according to today.com and other outlets.
The mom had her first child back in 1977, followed by eight children after she turned 50 — who were all born via C-section.
Her children include Svetlana, 45; Artiom, 36; twins Elisabeth and Maximilian, 12; Alexandra, 10; Leopold, 8; Anna, 7; Maria, 4 and Katharina, 2.
Hildebrandt told TODAY that she did not use any fertility drugs and did not have difficulty conceiving.
Her new baby Philipp was born via C-section at Charite Hospital in Berlin.
He weighed in at a "healthy" seven pounds, 13 ounces, although he was kept in an incubator.
For more Health articles, visit www.foxnews.com/health
In an interview with the German newspaper Bild, Hildebrandt shared her happiness in welcoming another child, noting that she feels "like I'm 35."
"We should encourage people to have more children!"
Professor Wolfgang Henrich, director of the Clinic for Obstetric Medicine at the Berlin Charite where Hildebrandt was treated, told Bild that her age and number of C-sections is an "absolute rarity in obstetric medicine and represented a challenge."
"Because of her particularly good physical constitution and mental strength, Ms. Hildebrandt managed the pregnancy well," he said.
"The operation was completely uncomplicated."
Hildebrandt confirmed with the publication, "I eat very healthily, swim regularly for an hour, run for two hours, don't smoke or drink, and have never used contraception."
"There is such a tendency to be unfriendly to children," Hildebrandt also told Bild.
"Many people would revise their judgment once they had contact with children. We should encourage people to have more children!"
Fox News Digital reached out to Hildebrandt for further comment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
Bed Bugs May Have Been The First Urban Pest to Ever Plague Humans
Humans were letting the bed bugs bite long before beds existed, and while they do live on other species, we're the main reason this notorious parasite is still going strong. In fact, bed bugs might have been the first pest to plague our cities – earlier than the black rat, for instance, which joined us in urban life about 15,000 years ago, and even the German cockroach, which only got the memo about 2,100 years ago. Researchers think the blood-sucking pests – Cimex lectularius – first jumped from their bat hosts onto a passing human some 50,000 years ago, a move which would change the course of the insect species forever. Human bed bugs, it turns out, have boomed since the Last Glacial Maximum about 20,000 years ago. But it's a different story for those populations that continued living on bats. "Initially with both populations, we saw a general decline that is consistent with the Last Glacial Maximum; the bat-associated lineage never bounced back, and it is still decreasing in size," says entomologist Lindsay Miles, from Virginia Tech. "The really exciting part is that the human-associated lineage did recover and their effective population increased." The researchers were able to track this evolution because the human bed bugs have a much narrower genetic diversity, since only a few 'founders' probably came with us when we abandoned life in caves. But our move into cities around 12,000 years ago is what really kicked off the human bed bug boom. This was only briefly interrupted when DDT was invented in the 1940s. Populations crashed, humans slept sweetly, and then five years later, the bed bugs were back. Since then, bed bugs have travelled around the world with us, and even become resistant to our pesticides. For now, it seems, bed bugs are here to stay. It's been a long-term relationship, after all. The research is published in Biology Letters. Your Brain Wrinkles Are Way More Important Than We Ever Realized Something Strange Happens to Your Eyes When You're Sexually Aroused 2-Year-Old Prodigy Joins 'High IQ' Club Mensa as Youngest Member Ever
UPI
2 days ago
- UPI
'Unite for Vets' rally in Washington, D.C., protest overhaul of VA
1 of 8 | Veterans, military families and demonstrators gather on the National Mall in Washington, D.C.,, to participate in a Unite for Veterans Rally to protest the Trump Administration's cuts to staffing and programs at the Department of Veterans Affairs. Photo by Annabelle Gordon/UPI | License Photo June 6 (UPI) -- Several thousand veterans converged on the National Mall on Friday at a rally among 200 events nationwide against a proposed overhaul that includes staffing reduction and some services shifted. The Veterans Administration counters the new proposed budget is higher than last year, processing of claims have sped up and it's easier to get benefits. Veterans, military families and others participated in the Unite for Veterans, Unite for America Rally on the 81st anniversary of D-Day, which was the Allies' amphibious invasion of German-occupied France. The protests, which were organized by a union, took place at 16 state capitol buildings and more than 100 other places across 43 states. "We are coming together to defend the benefits, jobs and dignity that every generation of veterans has earned through sacrifice," Unite for Veterans said on its website. "Veteran jobs, healthcare, and essential VA services are under attack. We will not stand by." Speakers in Washington included Democrats with military backgrounds: Sen. Tammy Duckworth of Illinois, former Rep. Conor Lamb of Pennsylvania and California Rep. Derek Tran. There were signs against President Donald Trump, VA Secretary Doug Collins and Elon Musk, the multi-billionaire who ran the Department of Government Efficiency. They said those leaders are betraying the country's promises to troops. "Are you tired of being thanked for our service in the public and stabbed in our back in private?" Army veteran Everett Kelly, the national president of the American Federation of Government Employees, asked the crowd. "For years, politicians on both sides of the aisle have campaigned on their support of veterans, but once they get into office, they cut our benefits, our services. They take every opportunity to privatize our health care." The Trump administration plans to cut 83,000 VA staffers and shift more money from the federal health care system to private-sector clinics. The administration's proposed budget for the VA, released on Friday, slashes spending for "medical services" by $12bn - or nearly 20% - an amount offset by a corresponding 50% boost in funding for veterans seeking healthcare in the private sector. The Department of Veterans Affairs employs approximately 482,000 people, including 500,000 workers at 170 hospitals and 1,200 local clinics in the nation's largest health care system. In all, there are 15.8 million veterans, which represents 6.1% of the civilian population 18 years and older. VA officials said the event was misguided. "Imagine how much better off veterans would be if VA's critics cared as much about fixing the department as they do about protecting its broken bureaucracy," VA press secretary Peter Kasperowicz said in a statement to UPI. "The Biden Administration's VA failed to address nearly all of the department's most serious problems, such as rising health care wait times, growing backlogs of veterans waiting for disability compensation and major issues with survivor benefits." Kasperowicz told UPI disability claims backlog is already down 25% since Trump took office on Jan. 20 after it increased 24% during the Biden administration. He said VA has opened 10 new healthcare clinics around the country, and Trump has proposed a 10% budget increase to $441.3 billion in fiscal year 2026. The administration's proposed budget for the VA reduces spending for "medical services" by $12 billion - or nearly 20% - which is offset by a 50% boost in funding for veterans seeking healthcare in the private sector. Kasperowicz said the "VA is accelerating the deployment of its integrated electronic health record system, after the program was nearly dormant for almost two years under the Biden Administration." The event was modeled after the Bonus Army protests of the 1930s, when veterans who served in World War I gathered in the nation's capital to demand extra pay denied after leaving the service. Irma Westmoreland, a registered nurse working at a VA hospital and the secretary-treasurer of National Nurses United, told the crowd in Washington: "It's important for every person to keep their job, from the engineering staff to the housekeeper to the dietary staff. When cuts are made, the nursing and medical staff will have to pick up all their work that needs to be done."
Vox
2 days ago
- Vox
We're secretly winning the war on cancer
is a senior editorial director at Vox overseeing the climate teams and the Unexplainable and The Gray Area podcasts. He is also the editor of Vox's Future Perfect section and writes the Good News newsletter. He worked at Time magazine for 15 years as a foreign correspondent in Asia, a climate writer, and an international editor, and he wrote a book on existential risk. Thousands of people gather on the National Mall in Washington, DC, on September 26, 1998, to demand that the cause, the care, and the cure of cancer be made top research and healthcare priorities in the US. Paul J. Richards/AFP via Getty Images On November 4, 2003, a doctor gave Jon Gluck some of the worst news imaginable: He had cancer — one that later tests would reveal as multiple myeloma, a severe blood and bone marrow cancer. Jon was told he might have as little as 18 months to live. He was 38, a thriving magazine editor in New York with a 7-month-old daughter whose third birthday, he suddenly realized, he might never see. 'The moment after I was told I had cancer, I just said 'no, no, no,'' Jon told me in an interview just last week. 'This cannot be true.' Living in remission The fact that Jon is still here, talking to me in 2025, tells you that things didn't go the way the medical data would have predicted on that November morning. He has lived with his cancer, through waves of remission and recurrence, for more than 20 years, an experience he chronicles with grace and wit in his new book An Exercise in Uncertainty. That 7-month-old daughter is now in college. You could say Jon has beaten the odds, and he's well aware that chance played some role in his survival. ('Did you know that 'Glück' is German for 'luck'?' he writes in the book, noting his good fortune that a random spill on the ice is what sent him to the doctor in the first place, enabling them to catch his cancer early.) Cancer is still a terrible health threat, one that is responsible for 1 in 6 deaths around the world, killing nearly 10 million people a year globally and over 600,000 people a year in the US. But Jon's story and his survival demonstrate something that is too often missed: We've turned the tide in the war against cancer. The age-adjusted death rate in the US for cancer has declined by about a third since 1991, meaning people of a given age have about a third lower risk of dying from cancer than people of the same age more than three decades ago. That adds up to over 4 million fewer cancer deaths over that time period. Thanks to breakthroughs in treatments like autologous stem-cell harvesting and CAR-T therapy — breakthroughs Jon himself benefited from, often just in time — cancer isn't the death sentence it once was. Our World in Data Getting better all the time There's no doubt that just as the rise of smoking in the 20th century led to a major increase in cancer deaths, the equally sharp decline of tobacco use eventually led to a delayed decrease. Smoking is one of the most potent carcinogens in the world, and at the peak in the early 1960s, around 12 cigarettes were being sold per adult per day in the US. Take away the cigarettes and — after a delay of a couple of decades — lung cancer deaths drop in turn along with other non-cancer smoking-related deaths. But as Saloni Dattani wrote in a great piece earlier this year, even before the decline of smoking, death rates from non-lung cancers in the stomach and colon had begun to fall. Just as notably, death rates for childhood cancers — which for obvious reasons are not connected to smoking and tend to be caused by genetic mutations — have fallen significantly as well, declining sixfold since 1950. In the 1960s, for example, only around 10 percent of children diagnosed with acute lymphoblastic leukemia survived more than five years. Today it's more than 90 percent. And the five-year survival rate for all cancers has risen from 49 percent in the mid-1970s to 69 percent in 2019. We've made strikes against the toughest of cancers, like Jon's multiple myeloma. Around when Jon was diagnosed, the five-year survival rate was just 34 percent. Today it's as high as 62 percent, and more and more people like Jon are living for decades. 'There has been a revolution in cancer survival,' Jon told me. 'Some illnesses now have far more successful therapies than others, but the gains are real.' Three cancer revolutions The dramatic bend in the curve of cancer deaths didn't happen by accident — it's the compound interest of three revolutions. While anti-smoking policy has been the single biggest lifesaver, other interventions have helped reduce people's cancer risk. One of the biggest successes is the HPV vaccine. A study last year found that death rates of cervical cancer — which can be caused by HPV infections — in US women ages 20–39 had dropped 62 percent from 2012 to 2021, thanks largely to the spread of the vaccine. Other cancers have been linked to infections, and there is strong research indicating that vaccination can have positive effects on reducing cancer incidence. The next revolution is better and earlier screening. It's generally true that the earlier cancer is caught, the better the chances of survival, as Jon's own story shows. According to one study, incidences of late-stage colorectal cancer in Americans over 50 declined by a third between 2000 and 2010 in large part because rates of colonoscopies almost tripled in that same time period. And newer screening methods, often employing AI or using blood-based tests, could make preliminary screening simpler, less invasive and therefore more readily available. If 20th-century screening was about finding physical evidence of something wrong — the lump in the breast — 21st-century screening aims to find cancer before symptoms even arise. Most exciting of all are frontier developments in treating cancer, much of which can be tracked through Jon's own experience. From drugs like lenalidomide and bortezomib in the 2000s, which helped double median myeloma survival, to the spread of monoclonal antibodies, real breakthroughs in treatments have meaningfully extended people's lives — not just by months, but years. Perhaps the most promising development is CAR-T therapy, a form of immunotherapy. Rather than attempting to kill the cancer directly, immunotherapies turn a patient's own T-cells into guided missiles. In a recent study of 97 patients with multiple myeloma, many of whom were facing hospice care, a third of those who received CAR-T therapy had no detectable cancer five years later. It was the kind of result that doctors rarely see. 'CAR-T is mind-blowing — very science-fiction futuristic,' Jon told me. He underwent his own course of treatment with it in mid-2023 and writes that the experience, which put his cancer into a remission he's still in, left him feeling 'physically and metaphysically new.' A welcome uncertainty While there are still more battles to be won in the war on cancer, and there are certain areas — like the rising rates of gastrointestinal cancers among younger people — where the story isn't getting better, the future of cancer treatment is improving. For cancer patients like Jon, that can mean a new challenge — enduring the essential uncertainty that comes with living under a disease that's controllable but which could always come back. But it sure beats the alternative. 'I've come to trust so completely in my doctors and in these new developments,' he said. 'I try to remain cautiously optimistic that my future will be much like the last 20 years.' And that's more than he or anyone else could have hoped for nearly 22 years ago. A version of this story originally appeared in the Good News newsletter. Sign up here!
